ZA985559B - Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives - Google Patents

Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives

Info

Publication number
ZA985559B
ZA985559B ZA985559A ZA985559A ZA985559B ZA 985559 B ZA985559 B ZA 985559B ZA 985559 A ZA985559 A ZA 985559A ZA 985559 A ZA985559 A ZA 985559A ZA 985559 B ZA985559 B ZA 985559B
Authority
ZA
South Africa
Prior art keywords
aüsoquinoline
tetrahydroimidazo
derivatives
aüsoquinoline derivatives
Prior art date
Application number
ZA985559A
Other languages
English (en)
Inventor
Dirk Leysen
Gerardus Stephanus Franc Ruigt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA985559B publication Critical patent/ZA985559B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA985559A 1997-06-26 1998-06-25 Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives ZA985559B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201950 1997-06-26

Publications (1)

Publication Number Publication Date
ZA985559B true ZA985559B (en) 1999-01-20

Family

ID=8228485

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985559A ZA985559B (en) 1997-06-26 1998-06-25 Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives

Country Status (27)

Country Link
US (1) US5994366A (xx)
EP (1) EP0887349B1 (xx)
JP (1) JP4339939B2 (xx)
KR (1) KR100540317B1 (xx)
CN (1) CN1139589C (xx)
AR (1) AR013132A1 (xx)
AT (1) ATE209649T1 (xx)
AU (1) AU737924B2 (xx)
BR (1) BR9802286A (xx)
CA (1) CA2241469C (xx)
CZ (1) CZ293265B6 (xx)
DE (1) DE69802624T2 (xx)
DK (1) DK0887349T3 (xx)
ES (1) ES2169471T3 (xx)
HK (1) HK1018059A1 (xx)
HU (1) HUP9801451A3 (xx)
ID (1) ID20494A (xx)
IL (1) IL124914A (xx)
NO (1) NO311028B1 (xx)
NZ (1) NZ330722A (xx)
PL (1) PL190281B1 (xx)
PT (1) PT887349E (xx)
RU (1) RU2204560C2 (xx)
SG (1) SG66484A1 (xx)
TR (1) TR199801175A1 (xx)
TW (1) TW513411B (xx)
ZA (1) ZA985559B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060653A1 (es) * 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624093A (en) * 1970-03-10 1971-11-30 American Home Prod 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols
US4100165A (en) * 1975-06-17 1978-07-11 Sandoz, Inc. Imidazo [2,1-a]isoquinolines

Also Published As

Publication number Publication date
IL124914A (en) 2000-10-31
PT887349E (pt) 2002-04-29
DE69802624D1 (de) 2002-01-10
AU737924B2 (en) 2001-09-06
KR19990007323A (ko) 1999-01-25
JPH1171373A (ja) 1999-03-16
ID20494A (id) 1998-12-31
SG66484A1 (en) 1999-07-20
CN1139589C (zh) 2004-02-25
HUP9801451A2 (hu) 1999-02-01
PL190281B1 (pl) 2005-11-30
DE69802624T2 (de) 2002-08-01
NZ330722A (en) 1999-08-30
EP0887349B1 (en) 2001-11-28
KR100540317B1 (ko) 2006-04-17
ES2169471T3 (es) 2002-07-01
CZ293265B6 (cs) 2004-03-17
JP4339939B2 (ja) 2009-10-07
CA2241469A1 (en) 1998-12-26
BR9802286A (pt) 2000-02-08
PL327053A1 (en) 1999-01-04
HU9801451D0 (en) 1998-08-28
TW513411B (en) 2002-12-11
US5994366A (en) 1999-11-30
CN1203916A (zh) 1999-01-06
DK0887349T3 (da) 2002-03-25
ATE209649T1 (de) 2001-12-15
CA2241469C (en) 2008-08-19
AU7319698A (en) 1999-01-07
NO982952L (no) 1998-12-28
NO982952D0 (no) 1998-06-25
CZ204898A3 (cs) 1999-08-11
TR199801175A1 (xx) 1999-01-18
NO311028B1 (no) 2001-10-01
EP0887349A1 (en) 1998-12-30
RU2204560C2 (ru) 2003-05-20
HK1018059A1 (en) 1999-12-10
IL124914A0 (en) 1999-01-26
HUP9801451A3 (en) 1999-03-29
AR013132A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
ZA979593B (en) Naphthyridine derivatives.
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
HUP9801168A3 (en) Triazinylaminostilbene derivatives
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
IL127399A0 (en) 1,3,8-Triaza-spiro (4,5) decan-4-on derivatives
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
HK1040991A1 (zh) 2-雜芳基-3，4-二氫-2h-吡咯衍生物
ZA982436B (en) Thiazolimine derivatives.
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA983116B (en) Arylsecocholadiene derivatives